Trial Profile
French national copaxone observatory
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Nov 2016
Price :
$35
*
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 17 Aug 2015 New trial record
- 23 Jun 2015 Results 5-year follow-up presented at the 1st Congress of the European Academy of Neurology.